Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24770339)

1.

Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.

Wu J, Shen SL, Chen B, Nie J, Peng BG.

PLoS One. 2014 Apr 25;9(4):e95849. doi: 10.1371/journal.pone.0095849. eCollection 2014.

2.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
3.

Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.

Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.

J Clin Pathol. 2012 Sep;65(9):808-14. doi: 10.1136/jclinpath-2012-200721. Epub 2012 Jun 25.

PMID:
22734007
4.

The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.

Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, Li JS, Liu WB.

J Cancer Res Clin Oncol. 2013 Jun;139(6):1043-54. doi: 10.1007/s00432-013-1415-3. Epub 2013 Mar 23.

PMID:
23525579
5.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

6.

Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.

Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J.

Hepatology. 2012 Dec;56(6):2242-54. doi: 10.1002/hep.25907.

PMID:
22711685
7.

Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.

Huang X, Qu P, Chen Y, Zhou X, Wu Y, Liu F, Wang D, Zhang J, An J.

Hum Pathol. 2014 Sep;45(9):1944-50. doi: 10.1016/j.humpath.2014.06.001. Epub 2014 Jun 18.

PMID:
25081539
8.

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.

Wang J, Li J, Shen J, Wang C, Yang L, Zhang X.

BMC Cancer. 2012 Jun 8;12:227. doi: 10.1186/1471-2407-12-227.

9.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567
10.

The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.

Lv Z, Zou H, Peng K, Wang J, Ding Y, Li Y, Ren X, Wang F, Chang R, Liang L, Ding Y.

PLoS One. 2013 Oct 17;8(10):e77473. doi: 10.1371/journal.pone.0077473. eCollection 2013.

11.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

12.

CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.

Liu F, Lv H, Jia X, Liu G, Li T, Xu Z, Li J.

J Surg Oncol. 2014 Aug;110(2):151-5. doi: 10.1002/jso.23598. Epub 2014 Mar 14.

PMID:
24634224
13.

Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.

Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang L, Ding Y.

J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.

PMID:
22168621
14.

FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.

Wang F, Qiao Y, Yu J, Ren X, Wang J, Ding Y, Zhang X, Ma W, Ding Y, Liang L.

PLoS One. 2013 Jun 27;8(6):e65495. Print 2013.

15.

Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.

Chen J, Liu WB, Jia WD, Xu GL, Ma JL, Ren Y, Chen H, Sun SN, Huang M, Li JS.

PLoS One. 2014 Jan 21;9(1):e85840. doi: 10.1371/journal.pone.0085840. eCollection 2014.

16.

Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma.

Cui X, Liu Y, Wan C, Lu C, Cai J, He S, Ni T, Zhu J, Wei L, Zhang Y, Qian H.

J Mol Histol. 2014 Feb;45(1):59-68. doi: 10.1007/s10735-013-9529-0. Epub 2013 Oct 9.

PMID:
24105272
17.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

18.

As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.

Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D.

Oncogene. 2014 Feb 13;33(7):909-20. doi: 10.1038/onc.2013.236. Epub 2013 Jul 1.

PMID:
23812429
19.

Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.

Huang X, Liu F, Zhu C, Cai J, Wang H, Wang X, He S, Liu C, Yao L, Ding Z, Zhang Y, Zhang T.

Dig Dis Sci. 2014 Apr;59(4):795-806. doi: 10.1007/s10620-013-2969-2. Epub 2013 Dec 25.

20.

Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma.

Song K, Gao Q, Zhou J, Qiu SJ, Huang XW, Wang XY, Fan J.

Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):177-84.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk